Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Barthel Index in a Middle-East Country: Translation, Validity and Reliability Publisher Pubmed



Oveisgharan S1, 2, 3 ; Shirani S1 ; Ghorbani A2 ; Soltanzade A2 ; Baghaei A1 ; Hosseini S1 ; Sarrafzadegan N2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Stroke Registry Unit, Isfahan Cardiovascular Research Center, WHO Collaborating Center, Isfahan, Iran
  2. 2. Neurology Department, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Isfahan, 84, 3rd St.
  4. 4. M. St.
  5. 5. 2nd M. Blvd, Iran

Source: Cerebrovascular Diseases Published:2006


Abstract

Background: In Iran, a Middle-East country, no disability scale has been translated and validated for use in stroke clinical trials. This study was designed to translate the Barthel Index and make its Persian translated form valid and reliable. Methods: All items of the Barthel Index were translated into Persian. Also, the Modified Rankin Scale (MRS) was also translated to Persian. Telephone interview was used as the method of data acquisition. Two interviewers were chosen for this means in order to accelerate data gathering and measure interrater agreement. Samples were selected from Isfahan Cardiovascular Research Center's Stroke Registry Unit, a WHO collaborating center in the center of Iran. All the patients were registered as stroke or intracerebral hemorrhage (ICH). These patients were inhabitants of Isfahan Province who had suffered from stroke or ICH between 12 and 24 months before data acquisition. Chronbach's alpha, test-retest reliability, concurrent validity with MRS, interrater agreement and item analysis were done for the translated questionnaire. Results: Translated questionnaires were filled by interview from 459 stroke patients. Their mean age was 68.11 ± 11.59 years. 243 of them were male (52.9%). Cronbach's alpha was 0.9354. Spearman's correlation coefficient between translated Barthel Index scores and MRS scores was -0.912. Spearman's correlation coefficient between 2 scores, to determine test-retest reliability was 0.989. Concordance correlation to determine interrater agreement was 0.994. All corrected item-total correlations were greater than 0.5. Conclusions: The Persian translated version of the Barthel Index is a reliable and valid questionnaire for use in stroke clinical trials. Copyright © 2006 S. Karger AG.
Related Docs
View other Related Docs
1. One-Year Survival and Prognostic Factors for Survival Among Stroke Patients: The Prove-Stroke Study, Journal of Research in Medical Sciences (2022)
2. Distribution by Location of Ct-Diagnosed Primary Intracerebral Hemorrhage in Isfahan, Journal of Research in Medical Sciences (2005)
3. Epidemiologic Evaluation of Stroke Risk Factors Among Rural-Urban Patients in Isfahan University Hospitals, Iran, Journal of Isfahan Medical School (2012)
4. Global, Regional, and National Burden of Stroke and Its Risk Factors, 1990-2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet Neurology (2021)
5. The Incidence and Mortality Rates Due to Stroke and Myocardial Infarction Following Implementing the Package of Essential Non-Communicable Diseases; a Historical Cohort Study, Journal of Cardiovascular and Thoracic Research (2022)
6. Stroke in Isfahan, Iran: Hospital Admission and 28-Day Case Fatality Rate, Cerebrovascular Diseases (2007)
7. Validity of the Iranian Version of Health Utility Index Mark 3 Quality of Life Questionnaire, Journal of Kerman University of Medical Sciences (2017)
8. Epidemiologic Evaluation and Seasonal Variations of Stroke Risk Factors Among Patients With First and Recurrent Stroke, Journal of Isfahan Medical School (2012)
Experts (# of related papers)
View all Related Experts
Mohammad Saadatnia (34)
Nizal Sarrafzadegan (23)
Other Related Docs
9. Metabolic Syndrome and the Risk of Ischemic Stroke, Journal of Stroke and Cerebrovascular Diseases (2017)
10. The Effect of Statin Therapy in Stroke Outcome: A Double Blind Clinical Trial, International Journal of Preventive Medicine (2012)
11. Comparison of Acute Ischemic Stroke Evaluation and the Etiologic Subtypes Between University and Nonuniversity Hospitals in Isfahan, Iran, International Journal of Stroke (2019)
12. Stroke Units: What Do They Do and What Should We Do?, Journal of Research in Medical Sciences (2008)
13. The Impact of Home-Based Exercise Rehabilitation on Functional Capacity in Patients With Acute Ischemic Stroke: A Randomized Controlled Trial, Home Health Care Management and Practice (2020)
14. Different Stroke Scales; Which Scale or Scales Should Be Used?, Caspian Journal of Internal Medicine (2021)
15. Low-Dose Versus Standard-Dose Alteplase for Intravenous Thrombolysis in Patients With Acute Ischemic Stroke in Iran: Results From the Safe Implementation of Treatments in Stroke Registry, Current Journal of Neurology (2021)
16. Public Stroke Knowledge, Awareness, and Response to Acute Stroke in Isfahan Iran: What Is Less or Misinterpreted in Developing Countries, Journal of Stroke and Cerebrovascular Diseases (2021)
17. A Multicenter Diagnostic Accuracy Study on Prehospital Stroke Screening Scales, Archives of Iranian Medicine (2021)
18. “Incidence, Characteristics and Prognosis of Cervical Artery Dissection-Induced Ischemic Stroke in Central Iran”, BMC Neurology (2022)
19. The Frequency of Recurrence in Primary Hypertensive Intracerebral Hemorrhage, Journal of Research in Medical Sciences (2006)
20. The Frequency of Antithrombotic Therapy in Management of Non-Valvular Atrial Fibrillation in Hospitalized Patients, Journal of Isfahan Medical School (2023)
21. Implementation of Home-Based Health Promotion Program to Improve Flow-Mediated Dilation Among Patients With Subacute Stroke, Journal of Education and Health Promotion (2020)
22. Predictors of Cerebral Venous Thrombosis and Arterial Ischemic Stroke in Young Asian Women, Journal of Stroke and Cerebrovascular Diseases (2012)
23. Dairy Consumption and Risk of Stroke: A Case‑Control Study, International Journal of Preventive Medicine (2016)
24. Secular Trends in Cardiovascular Mortality in Iran, With Special Reference to Isfahan, Acta Cardiologica (1999)
25. Reliability and Validity of the Persian Hit-6 Questionnaire in Migraine and Tension-Type Headache, Pain Practice (2014)
26. Is Friedewald Formula a Good Estimation for Low Density Lipoprotein Level in Iranian Population?, Journal of Research in Medical Sciences (2012)
27. A Case-Control Study on Potato Consumption and Risk of Stroke in Central Iran, Archives of Iranian Medicine (2013)
28. 15-Year Lipid Profile Effects on Cardiovascular Events Adjusted for Cardiovascular Risk Factors: A Cohort Study From Middle-East, Acta Cardiologica (2021)
29. Comparison of Changes in Serum Fibrinogen Level in Primary Intracranial Hemorrhage (Ich) and Ischemic Stroke, ARYA Atherosclerosis (2012)
30. Extracranial Cerebral Arterial Atherosclerosis in Iranian Patients Suffering Ischemic Strokes, Journal of Research in Medical Sciences (2006)
31. Relation of Stroke Risk Factors With Specific Stroke Subtypes and Territories, Iranian Journal of Public Health (2015)
32. Preliminary Investigation of Economics Issues in Hospitalized Patients With Stroke, International Journal of Preventive Medicine (2013)
33. Dietary Total Antioxidant Capacity in Relation to Stroke Among Iranian Adults, Nutritional Neuroscience (2020)
34. The Isfahan Cohort Study: Rationale, Methods and Main Findings, Journal of Human Hypertension (2011)
35. The Impact of Prothrombin (G20210a) Gene Mutation on Stroke in Youths, ARYA Atherosclerosis (2012)
36. Use of Cardiovascular Disease Secondary Prevention Medications in Four Middle East Countries in a Community Setting, Global Heart (2024)
37. Iran Quality of Care in Medicine Program (Iqcamp): Design and Outcomes, Archives of Iranian Medicine (2023)
38. Temporal Trends of Stroke Incidence Over 14 Years in Iran: Findings of a Large-Scale Multi-Centric Hospital-Based Registry, Neurology Asia (2023)
39. Neuroprotective Effects of Erythropoietin in Acute Ischemic Stroke, International Journal of Preventive Medicine (2013)
40. Knowladge, Attitude, and Practice (Kap) About the Risk Factors of Stroke in Isfahan, Iran, Journal of Isfahan Medical School (2011)
41. Estimation of Burden of Ischemic Heart Diseases in Isfahan, Iran, 2014: Using Incompleteness and Misclassification Adjustment Models, Journal of Diabetes and Metabolic Disorders (2017)
42. The Evaluation of Left Ventricular Diastolic Dysfunction in Patients With Non-Hemorrhagic Stroke and Atrial Fibrillation, ARYA Atherosclerosis (2017)
43. Incidence of Cardiovascular Diseases in an Iranian Population: The Isfahan Cohort Study, Archives of Iranian Medicine (2013)
44. Cultural Adaptation and Validation of the Persian Version of the Disabilities of the Arm, Shoulder and Hand (Dash) Outcome Measure, Clinical Rehabilitation (2008)
45. Ischemic Stroke in Young Asian Women: Risk Factors, Subtypes and Outcome, Cerebrovascular Diseases (2010)
46. Design and Methodology of Heart Failure Registry: Results of the Persian Registry of Cardiovascular Disease, ARYA Atherosclerosis (2019)
47. Asian Study of Cerebral Venous Thrombosis, Journal of Stroke and Cerebrovascular Diseases (2019)
48. Reliability and Validity of the Migraine Disability Assessment Scale Among Migraine and Tension Type Headache in Iranian Patients, BioMed Research International (2014)
49. Impact of Metabolic Syndrome on Ischemic Heart Disease - a Prospective Cohort Study in an Iranian Adult Population: Isfahan Cohort Study, Nutrition, Metabolism and Cardiovascular Diseases (2012)
50. Audit and Quality Assessment of National Persian Registry of Cardiovascular Disease(N-Prove) in Terms of Comorbidities, Angiography, and Angioplasty Characteristics in Iran, ARYA Atherosclerosis (2024)